UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018646
Receipt number R000021587
Scientific Title Combination of neuromuscular electrical stimulation and thermotherapy to prevent ICU-acquired weakness in a septic patient
Date of disclosure of the study information 2015/08/11
Last modified on 2022/08/16 12:58:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Combination of neuromuscular electrical stimulation and thermotherapy to prevent ICU-acquired weakness in a septic patient

Acronym

Neuromuscular electrical stimulation and thermotherapy in a septic patient

Scientific Title

Combination of neuromuscular electrical stimulation and thermotherapy to prevent ICU-acquired weakness in a septic patient

Scientific Title:Acronym

Neuromuscular electrical stimulation and thermotherapy in a septic patient

Region

Japan


Condition

Condition

Septic patient

Classification by specialty

Medicine in general Intensive care medicine Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to examine the effect of muscle strength and physical function, activity of daily living when discharged hospital

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Muscle strength, physical function, activity of daily living (first intervention, discharged ICU, discharged hospital)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

intervention group: transcutaneous EMS of the bilateral quadriceps (five times a week, 30 minutes each session)

Interventions/Control_2

intervention group: transcutaneous EMS and thermotherapy of the bilateral quadriceps (five times a week, 30 minutes each session)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The diagnosis of sepsis was defined by Intensive care physician in the ICU, fulfilled the criteria for septic shock

Key exclusion criteria

1. severe orthopedic or neurological disorders
2. unstable cardiac disease
3. weak skin
4. malignancy
5. pregnant

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Masatoshi
Middle name
Last name Hanada

Organization

Nagasaki University Hospital

Division name

Department of Rehabilitation Medicine

Zip code

852-8501

Address

1-7-1 Sakamoto, Nagasaki

TEL

0958197258

Email

mstshnd@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Hanada
Middle name
Last name Masatoshi

Organization

Nagasaki University Hospital

Division name

Department of Rehabilitation Medicine

Zip code

852-8501

Address

1-7-1 Sakamoto, Nagasaki

TEL

0958197258

Homepage URL


Email

mstshnd@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University Hospital

Address

Sakamoto 1-7-1, Nagasaki

Tel

0958194126

Email

mstshnd@nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 11 Day


Related information

URL releasing protocol

UMIN000018646

Publication of results

Unpublished


Result

URL related to results and publications

Unpublished

Number of participants that the trial has enrolled

5

Results

We could not analysis.

Results date posted

2022 Year 08 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Sepsis

Participant flow

Until hospital discharge

Adverse events

None

Outcome measures

urea 3-methyl histidine

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 01 Month 05 Day

Date of IRB

2015 Year 06 Month 30 Day

Anticipated trial start date

2015 Year 07 Month 01 Day

Last follow-up date

2018 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 08 Month 11 Day

Last modified on

2022 Year 08 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021587


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name